3rd Quarter - Report

ERVIN GRAVES STRATEGY GROUP, LLC for N BRERETON MEDICAL TECHNOLOGIES

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Development and use of medical technologies for pain management and opioid dependency treatment, including titration-based methodologies (FenBlock).

LobbyistCovered position, as disclosed
BRANDON KIRBY —
MARGARET LINEHAN —
OLIVER MEISSNER —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.